Clinical Decision Support Systems Market Size Worth $8.60 Billion by 2028: Grand View Research, Inc.

SAN FRANCISCO, Feb. 16, 2022 /PRNewswire/ -- The global clinical decision support systems market size is expected to reach USD 8.60 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.7% from 2021 to 2028. Surging demand for quality care is one of the primary factors driving the market for clinical decision support systems (CDSS). Constant lookout for reliable technology solutions by care providers is also expected to work in favor of the market. The growing interest in enhanced medical care and efficient decision-making is projected to fuel the adoption of CDSS and EHR.

Key Insights & Findings from the report:

• The standalone CDSS product segment accounted for the largest revenue share in 2020 owing to its low cost. The integrated EHR with CDSS segment is poised to witness noteworthy growth over the coming years due to the rapid adoption of healthcare IT solutions by clinicians.
• In terms of application, drug allergy alerts held the largest revenue share in 2020 owing to the rising burden of allergies.
• By delivery mode, the on-premise systems segment dominated the market with a share of over 40.0% in 2020 owing to its high adoption by healthcare organizations.
• Based on component, the CDSS software segment is expected to witness lucrative growth over the forecast period owing to novel innovations for technical support and interoperability of the CDSS software.
• North America dominated the market in 2020 due to the presence of a large number of key players and the high adoption of advanced technologies. Asia Pacific is estimated to register the highest CAGR of 13.0% during the forecast period.

Read 150-page market research report, "Clinical Decision Support Systems Market Size, Share & Trends Analysis Report by Product (Standalone CDSS, Integrated EHR with CDSS), By Application, By Delivery Mode, By Component, By Region, And Segment Forecasts, 2021 - 2028", published by Grand View Research.

Clinical Decision Support Systems Market Growth & Trends

To manage the COVID-19 pandemic, many initiatives are being undertaken by the government and community organizations to support the current healthcare system. These comprised front-line clinics by state governments, a volunteer panel of doctors, and many private telemedicine applications. CDSS is a playing a vital role during the pandemic as it is helping physicians make effective choices at the point of care. As a result, market players are capitalizing on this opportunity to address the problem and provide support to front-line doctors. For instance, in May 2020, DHIndia announced a collaboration with EHRC@IIITB and Healthelife to develop CDSS for COVID-19 screening. This collaboration also included the formation of a minimal triage application for front-line clinicians.

Decision support in critical health situations proves to be significant. Furthermore, these systems analyze patient medical records and provide a list of possible solutions from which the most appropriate is to be selected. Easy compatibility and interoperability of systems with different platforms have enhanced the growth prospects of the market. Collaborative efforts of researchers and software developers to make medical knowledge available to users are anticipated to contribute toward lucrative revenue generation over the forecast period.

At present, CDSS is being widely implemented across various healthcare functions such as diagnosis, drug prescription, and clinical investigations. The importance of CDSS has been acknowledged across several healthcare entities, including public and private healthcare sectors. Furthermore, healthcare organizations are undertaking initiatives for promoting the installation and integration of EHR and CDSS, which is expected to positively impact the market growth by encouraging hospital and healthcare groups to implement such solutions.

Market players are involved in strategic initiatives such as new product launches, product innovations, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in October 2021, DreaMed Diabetes AI LTD. proclaimed that it has received FDA Clearance for its Type 2 Diabetes AI-based CDSS, thereby enhancing its offering.

Clinical Decision Support Systems Market Segmentation

Grand View Research has segmented the global clinical decision support systems market on the basis of product, application, delivery mode, component, and region:

Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2016 - 2028)

• Standalone CDSS
• Integrated CPOE with CDSS
• Integrated E.H.R. with CDSS
• Integrated CDSS with CPOE & E.H.R.

Clinical Decision Support Systems Application Outlook (Revenue, USD Million, 2016 - 2028)

• Drug-drug Interactions
• Drug Allergy Alerts
• Clinical Reminders
• Clinical Guidelines
• Drug Dosing Support
• Others

Clinical Decision Support Systems Delivery Mode Outlook (Revenue, USD Million, 2016 - 2028)

• Web-based Systems
• Cloud-based Systems
• On-premise Systems

Clinical Decision Support Systems Component Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware
• Software
• Services

Clinical Decision Support Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East and Africa (MEA)
• Saudi Arabia
• South Africa
• Israel

List of Key Players of Clinical Decision Support Systems Market

• McKesson Corporation
• Cerner Corporation
• Siemens Healthineers GmbH
• Allscripts Healthcare, LLC
• athenahealth, Inc.
• NextGen Healthcare Inc.
• Koninklijke Philips N.V. (Royal Philips)
• IBM Corporation
• Agfa-Gevaert Group
• Wolters Kluwer N.V.

Check out more related market research studies published by Grand View Research:

• eClinical Solutions Market - The global eClinical solutions market size is expected to reach USD 21.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.6% from 2022 to 2030. Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth.
• Healthcare Software As A Service Market - The global healthcare software as a service market size is expected to reach USD 51.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is projected to register a CAGR of 19.5% from 2021 to 2028. The growing adoption of cloud computing in the healthcare industry is driving the growth.
• Healthcare Cloud Infrastructure Market - The global healthcare cloud infrastructure market size is expected to reach USD 142.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.7% from 2021 to 2028. The growing trend of healthcare digitalization, rising expenditures, overburdened health systems, rising traffic on the network, growing data siloes, and the emergence of remote working is contributing to the demand for healthcare cloud infrastructure systems and solutions.

Browse through Grand View Research's coverage of the Healthcare IT Industry

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]  
Web: https://www.grandviewresearch.com  
Grand View Compass | Grand View Pipeline  
Follow Us: LinkedIn | Twitter

SOURCE Grand View Research, Inc.